Cancer cell-secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model

被引:91
作者
Wu, CC
Chien, KY
Tsang, NM
Chang, KP
Hao, SP
Tsao, CH
Chang, YS
Yu, JS [1 ]
机构
[1] Chang Gung Univ, Dept Cell & Mol Biol, Taoyuan, Taiwan
[2] Chang Gung Univ, Dept Biochem, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Radiat Oncol, Linkou, Taiwan
[4] Chang Gung Univ, Grad Inst Basic Med Sci, Taoyuan, Taiwan
[5] Chang Gung Univ, Chang Gung Proteom Core Lab, Taoyuan, Taiwan
关键词
nasopharyngeal carcinoma; secreted proteins; tumor markers;
D O I
10.1002/pmic.200401133
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nasopharyngeal carcinoma (NPC) is commonly diagnosed late due to its deep location and vague symptoms. To identify biomarkers for early NPC diagnosis, secreted proteomes of two NPC cell lines were analyzed. Proteins in the NPC cell-line cultured media were systematically identified by SDS-PAGE combined with MALDI-TOF MS. Twenty-three proteins were found in cultured media from both NPC cell lines. Among them, fibronectin, Mac-2 binding protein (Mac-2 BP), and plasminogen activator inhibitor 1 (PAI-1) were further confirmed by Western blot analysis. These three proteins were highly expressed in NPC biopsies, but weakly or not expressed in normal nasopharyngeal. tissues. The serum levels of the three proteins were significantly higher in NPC patients (n = 46) than in normal controls (n = 47) (p < 0.01). NPC nude mice model (n = 9) also showed elevated levels of serum Mac-2 BP and PAI-1 compared with tumor-free mice (n = 9) (p < 0.01). Systematic analysis of cancer cell-secreted proteomes combined with animal tumor models can be a feasible, convenient strategy for searching multiple potential tumor markers. Furthermore, our work shows that fibronectin, Mac-2 BP, and PAI-1 may be potential markers for diagnosis of NPC.
引用
收藏
页码:3173 / 3182
页数:10
相关论文
共 72 条
[1]   Biology of prostate-specific antigen [J].
Balk, SP ;
Ko, YJ ;
Bubley, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :383-391
[2]   Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma [J].
Chan, KCA ;
Lo, YMD .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) :489-496
[3]   Comparative genomic hybridization analysis of nasopharygeal carcinoma: consistent patterns of genetic aberrations and clinicopathological correlations [J].
Chien, G ;
Yuen, PW ;
Kwong, D ;
Kwong, YL .
CANCER GENETICS AND CYTOGENETICS, 2001, 126 (01) :63-67
[4]   Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling [J].
Cho, WCS ;
Yip, TTC ;
Yip, C ;
Yip, V ;
Thulasiraman, V ;
Ngan, RKC ;
Yip, TT ;
Lau, WH ;
An, JSK ;
Law, SCK ;
Cheng, WW ;
Ma, VWS ;
Lim, CKP .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :43-52
[5]  
Connolly Y, 2001, INT J CANCER, V91, P692, DOI 10.1002/1097-0215(200002)9999:9999&lt
[6]  
::AID-IJC1108&gt
[7]  
3.0.CO
[8]  
2-G
[9]  
Dardari R, 2000, INT J CANCER, V86, P71, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt
[10]  
71::AID-IJC11&gt